TrialPanorama/TrialPanorama-database huggingface dataset:
Study 25994539 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 25994539 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 24135831 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 17200357 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 17200357 — Safety Biomarker (SAF): Interleukin 12
Study 9747867 — Predictive Biomarker (PRD): Hormone receptor
Study 31069191 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 29222139 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 24965303 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 27297375 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11336170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27930455 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 27930455 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21520442 — Surrogate Endpoint (SUR): Blood pressure
Study 21520442 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18067517 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16689001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16689001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16689001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27264092 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18158082 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21999905 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 19552746 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 19552746 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16139447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16139447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15123023 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study 9715781 — Surrogate Endpoint (SUR): Blood pressure
Study 19384216 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 19384216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17479208 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9288699 — Surrogate Endpoint (SUR): Blood pressure
Study 2852252 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2852252 — Surrogate Endpoint (SUR): Blood pressure
Study 8726951 — Surrogate Endpoint (SUR): Forced vital capacity
Study 14515935 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19047294 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 19047294 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 25132069 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 25132069 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 25132069 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 18484198 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 18484198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 15688960 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 9803987 — Surrogate Endpoint (SUR): Blood pressure
Study 19644849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21827440 — Surrogate Endpoint (SUR): Blood pressure
Study 18279736 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18279736 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18279736 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 18279736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15023597 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 15023597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 8706601 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 31759770 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26982667 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22018049 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 18073378 — Predictive Biomarker (PRD): Hormone receptor
Study 19351633 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 9730139 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8014692 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8513841 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 25504868 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 25504868 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 25504868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25504868 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 16443339 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 16443339 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10096976 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 24262762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24262762 — Safety Biomarker (SAF): Interleukin 1
Study 17377602 — Surrogate Endpoint (SUR): Serum creatinine
Study 17377602 — Surrogate Endpoint (SUR): Blood pressure
Study 9444800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29851760 — Surrogate Endpoint (SUR): Bone mineral density
Study 29851760 — Surrogate Endpoint (SUR): Serum calcium
Study 24101016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24101016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24101016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 18786088 — Surrogate Endpoint (SUR): Blood pressure
Study 11512311 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 26541906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24068549 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24068549 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24271646 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 15674406 — Surrogate Endpoint (SUR): Blood pressure
Study 376210 — Surrogate Endpoint (SUR): Blood pressure
Study 30739176 — Safety Biomarker (SAF): Hyaluronic acid
Study 25872171 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 25872171 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 25872171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25872171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25872171 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 21377715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21377715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21377715 — Surrogate Endpoint (SUR): Forced vital capacity
Study 19424036 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 15098129 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 15098129 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 7624494 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 7624494 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 7624494 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 7624494 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 19781403 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10966893 — Surrogate Endpoint (SUR): Bone mineral density
Study 30220556 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study 12044531 — Monitoring Biomarker (MOI): HBV DNA
Study 8595642 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23469601 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 15837441 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15837441 — Surrogate Endpoint (SUR): Blood pressure
Study 2655687 — Surrogate Endpoint (SUR): Blood pressure
Study 26245675 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26245675 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 16890417 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 16890417 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9201779 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 1747643 — Surrogate Endpoint (SUR): Blood pressure
Study 7116588 — Surrogate Endpoint (SUR): Blood pressure
Study 28641792 — Surrogate Endpoint (SUR): Blood pressure
Study 16612915 — Surrogate Endpoint (SUR): Blood pressure
Study 9111852 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 31407484 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20140437 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9213829 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 9213829 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 30661702 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 29282609 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20662329 — Surrogate Endpoint (SUR): Bone mineral density
Study 18309461 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25686857 — Safety Biomarker (SAF): Cytochrome c
Study 21722960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 7963711 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21600550 — Predictive Biomarker (PRD): PGR mRNA
Genes: PGR; NR3C3
Study 8126146 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 25757039 — Surrogate Endpoint (SUR): Blood pressure
Study 19382463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19382463 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 9812081 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9812081 — Surrogate Endpoint (SUR): Blood pressure
Study 8950297 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 23469080 — Safety Biomarker (SAF): C-X-C motif chemokine 5
Genes: CXCL5; ENA78; SCYB5
Study 19116328 — Surrogate Endpoint (SUR): Blood pressure
Study 23290323 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 18823986 — Surrogate Endpoint (SUR): Blood pressure
Study 31096012 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31096012 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 31096012 — Surrogate Endpoint (SUR): Blood pressure
Study 26963592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23392399 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23392399 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 8865083 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 22419732 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 20595675 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 31915906 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study 23620431 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 22070641 — Surrogate Endpoint (SUR): Blood pressure
Study 18711172 — Surrogate Endpoint (SUR): Bone mineral density
Study 11422429 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 2441633 — Monitoring Biomarker (MOI): HBV DNA
Study 18414111 — Surrogate Endpoint (SUR): Blood pressure
Study 27402235 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 18840367 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18840367 — Surrogate Endpoint (SUR): Blood pressure
Study 16880243 — Surrogate Endpoint (SUR): Serum creatinine
Study 28060083 — Surrogate Endpoint (SUR): Blood pressure
Study 25816110 — Surrogate Endpoint (SUR): Blood pressure
Study 15140340 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 9419168 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 329943 — Surrogate Endpoint (SUR): Blood pressure
Study 16234828 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 10905544 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 10168173 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 22761453 — Surrogate Endpoint (SUR): Blood pressure
Study 11434469 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 28120485 — Surrogate Endpoint (SUR): Blood pressure
Study 23234813 — Surrogate Endpoint (SUR): Bone mineral density
Study 17263088 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 9283511 — Surrogate Endpoint (SUR): Blood pressure
Study 7685921 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29846100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27583476 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 27583476 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 1887968 — Surrogate Endpoint (SUR): Blood pressure
Study 6693150 — Surrogate Endpoint (SUR): Blood pressure
Study 26990318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26990318 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 18159246 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 18159246 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10689269 — Surrogate Endpoint (SUR): Blood pressure
Study 31926340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31413542 — Predictive Biomarker (PRD): Liver iron
Study 21576636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19589270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19589270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19589270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16466589 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 22320902 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29880873 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 23582750 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 8675576 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8675576 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27986742 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 22370326 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28793880 — Monitoring Biomarker (MOI): Procalcitonin
Study 28793880 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23123868 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23123868 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 3948442 — Surrogate Endpoint (SUR): Blood pressure
Study 21189431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21189431 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21189431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18776057 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 17161072 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10660736 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 9070555 — Surrogate Endpoint (SUR): Blood pressure
Study 30475961 — Predictive Biomarker (PRD): DHCR7 mRNA
Genes: DHCR7; D7SR
Study 30475961 — Predictive Biomarker (PRD): CYP2R1 mRNA
Genes: CYP2R1
Study 30475961 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 30475961 — Surrogate Endpoint (SUR): Bone mineral density
Study 29262474 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29262474 — Surrogate Endpoint (SUR): Blood pressure
Study 16641282 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 16641282 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 11044164 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11044164 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 6125172 — Surrogate Endpoint (SUR): Blood pressure
Study 27657352 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 26715818 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 23867982 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 23867982 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 16967285 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 2338696 — Surrogate Endpoint (SUR): Blood pressure
Study 16949180 — Safety Biomarker (SAF): 51Cr-EDTA
Study 16338265 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 22626878 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 22626878 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7731155 — Surrogate Endpoint (SUR): Serum creatinine
Study 6626426 — Surrogate Endpoint (SUR): Blood pressure
Study 21947137 — Surrogate Endpoint (SUR): Bone mineral density
Study 17453747 — Surrogate Endpoint (SUR): Blood pressure
Study 10875487 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 8257124 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2984100 — Surrogate Endpoint (SUR): Blood pressure
Study 30556961 — Safety Biomarker (SAF): Hyaluronic acid
Study 25369831 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 25369831 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 25369831 — Surrogate Endpoint (SUR): Bone mineral density
Study 25369831 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14618331 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 9224079 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7957150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 28958804 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 21998477 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 31973765 — Surrogate Endpoint (SUR): Blood pressure
Study 29402848 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26259808 — Surrogate Endpoint (SUR): Blood pressure
Study 30205746 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 21194605 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study 17497175 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 12118903 — Surrogate Endpoint (SUR): Blood pressure
Study 9071195 — Surrogate Endpoint (SUR): Blood pressure
Study 3493903 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 20546277 — Surrogate Endpoint (SUR): Blood pressure
Study 22827973 — Predictive Biomarker (PRD): Hormone receptor
Study 20845296 — Surrogate Endpoint (SUR): Sperm parameters
Study 14571302 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14571302 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8901790 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30369310 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 11079649 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 29132482 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 22749926 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 22834649 — Surrogate Endpoint (SUR): Serum testosterone
Study 20485136 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7437240 — Surrogate Endpoint (SUR): Blood pressure
Study 31810194 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 31810194 — Surrogate Endpoint (SUR): Blood pressure
Study 17378192 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 14647218 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 10522582 — Predictive Biomarker (PRD): HR mRNA
Genes: HR